Clinic
Lakeshore Medical Clinic, LLC
Lakeshore Medical Clinic, LLC was paid $8.38M by Medicaid between Jan 2018 and Dec 2024, across 152 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 37% of everything it billed.
33Billing provider infoLAKESHORE MEDICAL CLINIC, LLC
SAINT FRANCIS, WI 53235
SAINT FRANCIS, WI 53235
33aNPI1003861188assigned 05/24/2006
33bProvider typeClinic/Center
28Total paid$8.38M
24GClaims327,195
24DCodes billed152
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Wisconsin
Rank by total paid#4 of 102
Median peer was paid$54K
This provider vs. median156×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RICHARDSON, KARA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 40,170 | $1.09M | |
| 2019 | 42,094 | $1.06M | |
| 2020 | 32,138 | $800K | |
| 2021 | 49,541 | $1.11M | |
| 2022 | 61,645 | $1.48M | |
| 2023 | 59,820 | $1.42M | |
| 2024incomplete | 41,787 | $1.42M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 37% | 77,982 | 71,632 | $3.06M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 69,626 | 64,481 | $1.94M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.6% | 5,145 | 4,665 | $304K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.9% | 4,150 | 4,052 | $245K |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | 2.8% | 12,577 | 4,420 | $231K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.6% | 16,088 | 6,715 | $220K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.1% | 3,170 | 2,939 | $179K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.7% | 4,506 | 4,297 | $142K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.5% | 5,534 | 2,527 | $129K |
| 99223 | Prolong inpt eval add15 m | 1.5% | 3,037 | 2,768 | $124K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.4% | 2,044 | 1,995 | $119K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.4% | 2,374 | 2,157 | $117K |
140 more codes
| 99000 | 1.4% | 31,406 | $117K | |
| 90686 | 1.2% | 9,489 | $97K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.1% | 3,920 | $89K |
| 99203 | Doctor's office visit, new patient (routine) | 1.0% | 2,012 | $86K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,656 | $79K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 898 | $62K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 1,725 | $59K |
| 11721 | <1% | 5,115 | $56K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 584 | $55K |
| 0240U | <1% | 1,625 | $52K | |
| 3008F | <1% | 5,226 | $46K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 1,001 | $46K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 367 | $45K |
| 91322 | <1% | 371 | $39K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,102 | $29K |
| 90677 | <1% | 516 | $25K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 406 | $23K |
| 20610 | <1% | 518 | $23K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,152 | $22K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 670 | $21K |
| 99243 | <1% | 310 | $18K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 201 | $18K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 747 | $17K |
| 0124A | <1% | 480 | $16K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,449 | $16K |
| 91321 | <1% | 217 | $15K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 582 | $14K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 540 | $14K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 378 | $14K |
| 90480 | <1% | 488 | $14K | |
| 80053 | Comprehensive metabolic panel | <1% | 1,538 | $13K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 810 | $12K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 453 | $12K |
| 87210 | <1% | 2,165 | $11K | |
| 90670 | <1% | 2,413 | $11K | |
| 99254 | <1% | 189 | $11K | |
| 11720 | <1% | 1,538 | $11K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 424 | $10K |
| 99442 | <1% | 627 | $10K | |
| 90723 | <1% | 1,399 | $10K | |
| 90647 | <1% | 1,150 | $9K | |
| 99253 | <1% | 169 | $9K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 435 | $8K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 258 | $8K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 78 | $8K |
| 90656 | <1% | 380 | $7K | |
| 92567 | <1% | 434 | $7K | |
| 0134A | <1% | 191 | $6K | |
| 0064A | <1% | 193 | $6K | |
| 93015 | <1% | 138 | $6K | |
| 98926 | <1% | 255 | $6K | |
| 96127 | <1% | 970 | $5K | |
| 90680 | <1% | 627 | $5K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 92 | $5K |
| 90688 | <1% | 323 | $5K | |
| 0054A | <1% | 150 | $5K | |
| 90672 | <1% | 277 | $5K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 66 | $5K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 711 | $5K |
| 90746 | <1% | 87 | $5K | |
| 0071A | <1% | 111 | $4K | |
| 92523 | <1% | 30 | $4K | |
| 95816 | <1% | 189 | $4K | |
| 82075 | <1% | 253 | $4K | |
| 95819 | <1% | 172 | $4K | |
| 85610 | <1% | 1,159 | $4K | |
| 0051A | <1% | 108 | $4K | |
| 0072A | <1% | 86 | $3K | |
| 0111A | <1% | 112 | $3K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 224 | $3K |
| 98940 | <1% | 209 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 127 | $3K |
| 51701 | <1% | 95 | $3K | |
| 90633 | <1% | 448 | $3K | |
| 76642 | <1% | 52 | $3K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 51 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,529 | $2K |
| 81001 | <1% | 1,014 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 370 | $2K |
| 36416 | <1% | 960 | $2K | |
| 0001A | <1% | 56 | $2K | |
| 0002A | <1% | 54 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 280 | $2K |
| 90739 | <1% | 16 | $2K | |
| 0112A | <1% | 48 | $1K | |
| 0004A | <1% | 38 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 138 | $1K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 154 | $1K |
| 99383 | <1% | 24 | $1K | |
| 90660 | <1% | 85 | $1K | |
| 0154A | <1% | 32 | $1K | |
| 99220 | <1% | 29 | $1K | |
| 99152 | <1% | 29 | $950.33 | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | <1% | 16 | $875.49 |
| 90651 | <1% | 161 | $830.23 | |
| 99306 | Prolong nursin fac eval 15m | <1% | 32 | $807.11 |
| 97162 | <1% | 13 | $753.32 | |
| 99385 | <1% | 13 | $741.52 | |
| 81025 | <1% | 86 | $738.69 | |
| 90685 | <1% | 222 | $731.43 | |
| 69210 | <1% | 65 | $698.19 | |
| 99441 | <1% | 83 | $691.90 | |
| 99443 | <1% | 30 | $656.59 | |
| 80061 | Lipid panel | <1% | 68 | $656.23 |
| 83037 | <1% | 100 | $592.42 | |
| 99421 | <1% | 57 | $577.09 | |
| 93793 | <1% | 108 | $475.27 | |
| 0121A | <1% | 14 | $462.87 | |
| 90715 | <1% | 28 | $461.93 | |
| 92579 | <1% | 18 | $444.76 | |
| 99225 | <1% | 21 | $427.92 | |
| 0053A | <1% | 13 | $423.95 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 79 | $423.04 |
| 80050 | General health panel | <1% | 13 | $411.29 |
| 99226 | <1% | 16 | $410.85 | |
| 90710 | <1% | 65 | $354.99 | |
| 81003 | <1% | 224 | $320.93 | |
| 81002 | <1% | 118 | $301.47 | |
| 96380 | <1% | 13 | $300.60 | |
| 82962 | <1% | 123 | $284.38 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 10,053 | $280.12 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 12 | $276.68 |
| 98942 | <1% | 43 | $224.77 | |
| 92552 | <1% | 12 | $200.52 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 24 | $197.43 |
| 90662 | <1% | 14 | $173.64 | |
| 90734 | <1% | 54 | $173.37 | |
| 87081 | <1% | 36 | $146.65 | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 12 | $142.50 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 12 | $105.56 |
| 99221 | <1% | 75 | $93.50 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 75 | $89.44 |
| 90681 | <1% | 27 | $83.80 | |
| 51798 | <1% | 15 | $80.71 | |
| 85027 | <1% | 12 | $74.15 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 12 | $1.46 |
| 97014 | 0% | 565 | $0.00 | |
| 91305 | 0% | 17 | $0.00 | |
| 91313 | 0% | 29 | $0.00 | |
| 91312 | 0% | 91 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRICHARDSON, KARA (ASSISTANT TREASURER)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.